This trial is active, not recruiting.

Condition patients in icu
Sponsor Ludwig-Maximilians - University of Munich
Collaborator University Hospital Muenster
Start date May 2010
End date May 2011
Trial size 4000 participants
Trial identifier NCT01122277, 337 -09/2009-366-f-S


The purpose of this observational study is the prospective documentation and evaluation of the status quo of volume therapy in German intensive care units.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - ICU patients with an indication for fluid/volume therapy Exclusion Criteria: - Patients hospitalized by order of a court of law or a government agency

Additional Information

Official title Klinisches Register RaFTinG - Rational Fluid Therapy in Germany
Principal investigator Matthias Jacob, MD
Description The purpose of RaFTinG is the prospective documentation and evaluation of the demographic, diagnostic and therapeutic characteristics of unselected patients and their treatment in intensive care units (ICU) in Germany. Documentation will not only include their stay in the ICU but a follow up query 90 days after discharge from the ICU.
Trial information was received from ClinicalTrials.gov and was last updated in July 2011.
Information provided to ClinicalTrials.gov by Ludwig-Maximilians - University of Munich.